Results Of A Phase 2 Study Of Neflamapimod 80mg Twice-daily In Dementia With Lewy Bodies

Frédéric Blanc, MD, PhD1,2, Anne Botzung, PhD1, Claire Hourregue, MD3, Agathe Vrillon, MD, PhD4, Alexandra Fayel, MSc5, Candice Muller, MD1, Catherine Demuynck, MD1, Jeanne Merignac, MSc1, Timothée Albasser, MSc1, Alix Ravier, MD1, Fabienne Saab, MSc1, Fanny Huselstein, MSc1, Ajit Chavan, PhD6, Jennifer Conway6, Nathalie Adda, PhD6, John Alam, MD7, Claire Paquet, MD, PhD3

1Service of Gerontology-Neuro-Psy-Research and Memory Clinic (CM2R), University Hospital of Strasbourg, Strasbourg, France, 2 ICube Laboratory UMR 7357, IMIS team, University of Strasbourg and CNRS, Strasbourg, France, 34Cognitive Neurology Center, AP-HP, Paris, France, 5AP-HP, Paris, France, 6Cervomed, Boston, MA,USA, 7CervoMed, Inc., Boston, MA, USA.